🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this study is to visualize the deposition of topical 0.3% roflu...
Status
Unknown
Location
Rao Dermatology
Start Date
2024-05-28
Trial ID
NCT06440473
Treatments Being Tested
This is a double-blind, parallel group, vehicle-controlled study to assess ...
Status
Completed
Location
Arcutis Biotherapeutics Clinical Site 127
Start Date
2019-12-20
Trial ID
NCT04211363
Treatments Being Tested
This study will assess the safety and efficacy of ARQ-151 cream vs vehicle ...
Status
Completed
Location
Arcutis Clinical Site 31
Start Date
2021-02-24
Trial ID
NCT04773600
Treatments Being Tested
This study is being done to obtain descriptive classifications of pruritus ...
Status
Recruiting
Location
Integrative Skin Science and Research
Start Date
2026-07-21
Trial ID
NCT07560618
Treatments Being Tested
Psoriasis affecting sensitive anatomical regions, such as the skin folds (f...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04-01
Trial ID
NCT07543640
Treatments Being Tested
This study investigates the efficacy of topical roflumilast foam in patient...
Status
Not Yet Recruiting
Location
Harrison Dermatology
Start Date
2026-08-10
Trial ID
NCT07689188
Treatments Being Tested
This was a parallel group, double blind, vehicle-controlled study assessed ...
Status
Completed
Location
Arcutis Biotherapeutics Clinical Site 19
Start Date
2019-12-04
Trial ID
NCT04091646
Treatments Being Tested
This study will assess the safety and efficacy of ARQ-151 cream applied onc...
Status
Completed
Location
Arcutis Biotherapeutics Clinical Site 203
Start Date
2020-02-12
Trial ID
NCT04286607
Treatments Being Tested
An open-label single center, proof of concept study evaluating the efficacy...
Status
Recruiting
Location
Derm Texas
Start Date
2025-08-01
Trial ID
NCT07105254
Treatments Being Tested
This is a Phase 2, open label, maximal usage PK and safety study of ARQ-151...
Status
Completed
Location
Arcutis Clinical Site 603
Start Date
2021-03-01
Trial ID
NCT04746911
Treatments Being Tested